» Articles » PMID: 2731316

Influence of Site on the Chemosensitivity of Transplantable Murine Colon Tumours to Flavone Acetic Acid (LM975, NSC 347512)

Overview
Specialty Oncology
Date 1989 Jan 1
PMID 2731316
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

A number of experimental studies have demonstrated significant responses of s.c. solid tumours to flavone acetic acid (FAA). Clinical studies to date have been disappointing, with no objective responses being seen. The present study demonstrated that the tumour site is important for the anti-tumour action of FAA against two transplantable adenocarcinoma lines (MAC) in NMRI mice. Responses were achievable only when the tumours were implanted s.c. Ascitic or systemic tumours did not respond to FAA. Experimentally achievable plasma levels of FAA were not sufficient to induce significant cell kills in either MAC 15A or MAC 26 cell lines in vitro. A poor correlation exists between in vitro and in vivo responses, as the clonogenic assay could not predict the response of the solid MAC tumours grown s.c. The in vitro data indicated that the length of exposure to FAA was important, with long exposure times being necessary for cytotoxicity to develop, in these tumour cell lines. These studies imply that more than one mechanism is involved, and it is likely that the activity of FAA against s.c. tumours relies at least in part on a specific biological feature of tumours in this site. However, it may still be possible to achieve systemic tumour cell kill in vivo by increasing drug-exposure times.

Citing Articles

DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2'3'-cGAMP, induces M2 macrophage repolarization.

Downey C, Aghaei M, Schwendener R, Jirik F PLoS One. 2014; 9(6):e99988.

PMID: 24940883 PMC: 4062468. DOI: 10.1371/journal.pone.0099988.


In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug.

Grosios K, Holwell S, McGown A, Pettit G, Bibby M Br J Cancer. 1999; 81(8):1318-27.

PMID: 10604728 PMC: 2362967. DOI: 10.1038/sj.bjc.6692174.


Preclinical in vitro and in vivo activity of 5,6-dimethylxanthenone-4-acetic acid.

Laws A, Matthew A, Double J, Bibby M Br J Cancer. 1995; 71(6):1204-9.

PMID: 7779712 PMC: 2033820. DOI: 10.1038/bjc.1995.234.


The use of vascularised spheroids to investigate the action of flavone acetic acid on tumour blood vessels.

Zwi L, Baguley B, Gavin J, Wilson W Br J Cancer. 1990; 62(2):231-7.

PMID: 2386739 PMC: 1971803. DOI: 10.1038/bjc.1990.266.


Flavone acetic acid antitumour activity against a mouse pancreatic adenocarcinoma is mediated by natural killer cells.

Damia G, Tagliabue G, Allavena P, DIncalci M Cancer Immunol Immunother. 1990; 32(4):241-4.

PMID: 2261598 PMC: 11038864. DOI: 10.1007/BF01741707.


References
1.
Murray J, Randhawa V, Denekamp J . The effects of melphalan and misonidazole on the vasculature of a murine sarcoma. Br J Cancer. 1987; 55(3):233-8. PMC: 2001746. DOI: 10.1038/bjc.1987.45. View

2.
Smith G, Calveley S, Smith M, Baguley B . Flavone acetic acid (NSC 347512) induces haemorrhagic necrosis of mouse colon 26 and 38 tumours. Eur J Cancer Clin Oncol. 1987; 23(8):1209-11. DOI: 10.1016/0277-5379(87)90157-x. View

3.
Schroyens W, Dodion P, Sanders C, Loos M, Dethier N, Delforge A . In vitro chemosensitivity testing of flavone acetic acid (LM975; NSC 347512) and its diethylaminoethyl ester derivative (LM985; NSC 293015). Eur J Cancer Clin Oncol. 1987; 23(8):1135-9. DOI: 10.1016/0277-5379(87)90146-5. View

4.
Bibby M, Double J, Phillips R, Loadman P, Gummer J . Experimental anti-tumor effects of flavone acetic acid (LM975). Prog Clin Biol Res. 1988; 280:243-6. View

5.
Corbett T, Bissery M, Wozniak A, Plowman J, Polin L, Tapazoglou E . Activity of flavone acetic acid (NSC-347512) against solid tumors of mice. Invest New Drugs. 1986; 4(3):207-20. DOI: 10.1007/BF00179586. View